The American Red Cross is dedicated to partnering with clients as a provider of cell and gene therapy source materials and collection services. Our collection services can support both clinical trials and commercial therapies. We also offer a full range of source materials that will support your work from bench research to late-stage development. By leveraging our nationwide collections footprint and over a decade of experience in manufacturing, donor resourcing, and clinical apheresis, we are uniquely positioned to be your cell sourcing and autologous collections provider offering customized cell and gene therapy solutions to meet your unique requirements.

Red Cross Leukopaks are collected via leukapheresis at FDA-registered collection centers from IRB-consented, pre-screened healthy donors. By tapping into the Red Cross’s network, you gain access to a reliable flow of high-quality starting materials designed to support the speed and efficiency of your cell sourcing operations.